NCT02806440View on ClinicalTrials.gov

Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 1, 2019

Study Completion Date

September 1, 2022

Conditions
Fibromyalgia
Interventions
DRUG

Low dose naltrexone

Active comparator

DRUG

Placebo

Placebo comparator

Trial Locations (1)

7200

Multidisciplinary Pain Centre, Grindsted

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02806440 - Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? | Biotech Hunter | Biotech Hunter